Clonazepam Tablet
Product Images NDC 71335-2509

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 71335-2509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Clonazepam Tablets C Iv Structure)

FDA Label Image

Image Description (Clonazepam Tablets Structure)

Image Description (Clonazepam Tablets Structure)
Chemical structure diagram of clonazepam, showing its molecular components including a benzodiazepine core with chlorine and nitro substituents.*
FDA Label Image

Label (Lbl713352509)

Label (Lbl713352509)
ClonazePAM Tablets, USP 0.5 mg oral tablets in a 20 tablet package. The label lists Bryant Ranch Prepack as the repackager and Rubicon Research Private Limited as the manufacturer. It includes storage instructions, a QR code for dosage information, and the NDC 71335-2509-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.